| Catherine Ndjeukam Tchanque-fossuo, MD, MS | |
|
10151 Montgomery Blvd Ne Bldg 1, Albuquerque, NM 87111-3670 | |
| (505) 273-5054 | |
| (505) 855-5533 |
| Full Name | Catherine Ndjeukam Tchanque-fossuo |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 10151 Montgomery Blvd Ne Bldg 1, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558588830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | MD2021-0742 (New Mexico) | Secondary |
| 207N00000X | Dermatology | MD2021-0742 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Dermatology Consultants Pc | 4880777432 | 5 |
News Archive
A study led by Nanyang Technological University, Singapore has revealed the effects of the stress of parenting in the brains of both mothers and their children.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, "The E3 Advantage." The next webcast will be on November 4th at 2 p.m. ET with the topic, "Looking into the Future of Healthcare" including "The Future of Pharmacy" presented by CVS Caremark. To attend, register at www.mebs.com.
Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.
A new American Cancer Society report outlines 21 challenges and needs for global tobacco control, covering the wide range of issues to be addressed and expertise needed to reduce the rising tide of tobacco use worldwide, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry.
› Verified 9 days ago
| Entity Name | Western Dermatology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174653299 PECOS PAC ID: 4880777432 Enrollment ID: O20080206000203 |
News Archive
A study led by Nanyang Technological University, Singapore has revealed the effects of the stress of parenting in the brains of both mothers and their children.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, "The E3 Advantage." The next webcast will be on November 4th at 2 p.m. ET with the topic, "Looking into the Future of Healthcare" including "The Future of Pharmacy" presented by CVS Caremark. To attend, register at www.mebs.com.
Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.
A new American Cancer Society report outlines 21 challenges and needs for global tobacco control, covering the wide range of issues to be addressed and expertise needed to reduce the rising tide of tobacco use worldwide, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Ndjeukam Tchanque-fossuo, MD, MS 10151 Montgomery Ne Bldg 1 St A, Albuquerque, NM 87111-3670 Ph: (505) 273-5054 | Catherine Ndjeukam Tchanque-fossuo, MD, MS 10151 Montgomery Blvd Ne Bldg 1, Albuquerque, NM 87111-3670 Ph: (505) 273-5054 |
News Archive
A study led by Nanyang Technological University, Singapore has revealed the effects of the stress of parenting in the brains of both mothers and their children.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced it recently received clearance from the European Medicines Agency to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, "The E3 Advantage." The next webcast will be on November 4th at 2 p.m. ET with the topic, "Looking into the Future of Healthcare" including "The Future of Pharmacy" presented by CVS Caremark. To attend, register at www.mebs.com.
Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.
A new American Cancer Society report outlines 21 challenges and needs for global tobacco control, covering the wide range of issues to be addressed and expertise needed to reduce the rising tide of tobacco use worldwide, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry.
› Verified 9 days ago
Dr. Willliam F Willis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Albuquerque, NM 87109 Phone: 505-884-7070 Fax: 505-884-6018 | |
R. Steven Padilla, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1021 Medical Arts Ave Ne, Albuquerque, NM 87102 Phone: 505-272-4947 | |
Phillip Strange, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1021 Medical Arts Ave Ne, Msc09 4240, Albuquerque, NM 87102 Phone: 505-272-6222 | |
Carol Purcell, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10151 Montgomery Blvd Ne Bldg 1, Suite A, Albuquerque, NM 87111 Phone: 505-855-5503 Fax: 505-855-5533 | |
Dr. Heidi Elizabeth Fleischmann, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7520 Montgomery Blvd Ne, Bldg D4, Albuquerque, NM 87109 Phone: 505-884-7070 Fax: 505-884-6018 | |
Dr. Emily M Altman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 933 Bradbury Dr Se Ste 2222, Albuquerque, NM 87106 Phone: 505-272-6000 Fax: 505-272-6228 | |
Shelly Ann Stepenaskie, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Woodward Pl Ne, Albuquerque, NM 87102 Phone: 505-938-8296 Fax: 505-938-8688 |